OBJECTIVE: The purpose of this study was to evaluate the efficacy of percutaneous radiofrequency ablation of hepatic neuroendocrine metastases for symptomatic relief of neuroendocrine syndromes. CONCLUSION: Percutaneous radiofrequency ablation, a minimally invasive technique, is an effective and safe way to reduce systemic symptoms in patients with hepatic metastases from neuroendocrine neoplasms.
OBJECTIVE: The purpose of this study was to evaluate the efficacy of percutaneous radiofrequency ablation of hepatic neuroendocrine metastases for symptomatic relief of neuroendocrine syndromes. CONCLUSION: Percutaneous radiofrequency ablation, a minimally invasive technique, is an effective and safe way to reduce systemic symptoms in patients with hepatic metastases from neuroendocrine neoplasms.
Authors: P L Pereira; S Clasen; A Boss; D Schmidt; C Gouttefangeas; C Burkart; J Wiskirchen; G Tepe; C D Claussen Journal: Radiologe Date: 2004-04 Impact factor: 0.635
Authors: Liesbeth M Veenendaal; Inne H M Borel Rinkes; Cornelis J M Lips; Richard van Hillegersberg Journal: World J Surg Oncol Date: 2006-06-26 Impact factor: 2.754
Authors: Liselot B J van Iersel; Ellen J Hoekman; Hans Gelderblom; Alexander L Vahrmeijer; Els L van Persijn van Meerten; Fred G J Tijl; Henk H Hartgrink; Peter J K Kuppen; Johan W R Nortier; Rob A E M Tollenaar; Cornelis J H van de Velde Journal: Ann Surg Oncol Date: 2008-05-10 Impact factor: 5.344